DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slid 2.79% to $556.81 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.57% to 4,982.77 and Dow Jones Industrial Average falling 0.84% to 37,645.59.
This was the stock's fourth consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 54.03% short of its 52-week high of $1,211.20, which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ fell 3.26% to $280.26, Moderna Inc. $(MRNA)$ fell 3.90% to $24.64, and Gilead Sciences Inc. $(GILD)$ fell 2.21% to $103.19.
Trading volume (1.1 M) eclipsed its 50-day average volume of 979,602.
Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 08, 2025 16:43 ET (20:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。